Healthcare Sales & Marketing Network News: Mylan

Searching News Database: Mylan

HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2021
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals

HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Sep 2020
Mylan to Acquire Aspen's Thrombosis Business in Europe
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 19 Aug 2020
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera(R)
Biopharmaceuticals Generics Neurology Product Launch

HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 9 Mar 2020
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Feb 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 18 Dec 2019
Pfizer and Mylan Announce Two Future Viatris Board Members
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 21 Nov 2019
STI Pharma Appoints Frank Mullery as President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Jul 2019
Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 8 Apr 2019
F2G Appoints Dr. Patrick Vink as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Feb 2019
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
Biopharmaceuticals Drug Delivery Generics Product Launch

HSMN NewsFeed - 13 Dec 2018
Sanofi's Formulation Patents on Multibillion-Dollar Lantus(R) are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
Biopharmaceuticals Generics Endocrinology Litigation

HSMN NewsFeed - 4 Dec 2018
Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid(R) SoluTab Delayed-Release Orally Disintegrating Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 31 Oct 2018
Shavit Capital Completes $100 Million Investment Round for Its Fifth Fund
Biopharmaceuticals Devices Venture Capital

HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Biopharmaceuticals Generics Oncology Regulatory

HSMN NewsFeed - 13 Sep 2018
Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc(R) Injection in Single-Dose Bags
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 8 Aug 2018
Statement from Mylan's Board of Directors
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
Biopharmaceuticals Neurology Generics Product Launch

HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Biopharmaceuticals Generics

HSMN NewsFeed - 16 May 2018
Roivant Expands Senior Leadership with Key Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2018
GT Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Apr 2018
Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 28 Mar 2018
Mylan Introduces Symfi(TM) Triple Combo Once-Daily HIV Treatment in the U.S.
Biopharmaceuticals HIV/AIDS FDA Product Launch

HSMN NewsFeed - 20 Mar 2018
Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Biopharmaceuticals Generics Oncology Product Launch

HSMN NewsFeed - 2 Mar 2018
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Biopharmaceuticals HIV/AIDS Product Launch

HSMN NewsFeed - 1 Feb 2018
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
Biopharmaceuticals HIV/AIDS Generics Product Launch

HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Dec 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2017
Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus(R) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 4 Dec 2017
Mylan and Aspen Announce Launch of Generic Busulfex(R) Injection
Biopharmaceuticals Oncology Generics Product Launch

HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2017
Mylan Launches First AP-rated Generic Avelox(R) Injection
Biopharmaceuticals Product Launch

HSMN NewsFeed - 13 Sep 2017
Mylan Names Dennis Zeleny as Chief Human Relations Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Aug 2017
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba(TM)) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
Biopharmaceuticals Licensing

HSMN NewsFeed - 17 Aug 2017
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen(R) Auto-Injector
Biopharmaceuticals Drug Delivery Litigation Reimbursement

HSMN NewsFeed - 10 Aug 2017
Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2017
Dance Biopharm Appoints Steve Thornton to Board of Directors
Biopharmaceuticals Drug Delivery Endocrinology Personnel

HSMN NewsFeed - 2 Jun 2017
Mylan Launches Generic Azilect(R) Tablets
Biopharmaceuticals Neurology Generics FDA Product Launch

HSMN NewsFeed - 2 Jun 2017
Mylan Launches Generic Reclast(R) Injection
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 28 Mar 2017
Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Biopharmaceuticals Oncology Generics Licensing

HSMN NewsFeed - 10 Mar 2017
Mylan Launches Generic Pristiq(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 18 Jan 2017
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Dec 2016
Apricus Biosciences Announces the Launch of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
Biopharmaceuticals Product Launch

HSMN NewsFeed - 18 Nov 2016
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 25 Aug 2016
Mylan Taking Immediate Action to Further Enhance Access to EpiPen(R) (Epinephrine Injection, USP) Auto-Injector
Biopharmaceuticals Devices Drug Delivery Reimbursement

HSMN NewsFeed - 2 Aug 2016
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Aug 2016
Mylan Launches Generic Dexedrine(R) Capsules
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 1 Aug 2016
Mylan Launches Generic Propecia(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 25 Jul 2016
Apricus Biosciences Further Expands Existing Vitaros(R) Partnership with Ferring Pharmaceuticals in Europe and Asia
Biopharmaceuticals Distribution

HSMN NewsFeed - 20 Jul 2016
Mylan Launches Generic Crestor(R) Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 12 Jul 2016
Federal Circuit Rules for The Medicines Company in Angiomax(R) (bivalirudin) Patent Litigation
Biopharmaceuticals Cardiology Litigation

HSMN NewsFeed - 6 Jul 2016
Mylan Launches Generic Fenoglide(R) Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 12 May 2016
Mylan Launches Generic Frova(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jan 2016
Mylan Launches Generic Felbatol(R) Tablets
Biopharmaceuticals Generics Neurology Product Launch

HSMN NewsFeed - 11 Jan 2016
Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Nov 2015
Mylan Launches Generic AXERT(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2015
Mylan Launches One of First Generic Lescol XL(R) Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 14 Sep 2015
Mylan Commences Offer to Acquire Perrigo
Biopharmaceuticals Generic Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2015
Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2015
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2015
Pulmatrix Appoints William Duke, Jr., as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Mar 2015
Mylan Launches Generic Antabuse(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Feb 2015
Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi(R) and Harvoni(R) in India
Biopharmaceuticals Distribution

HSMN NewsFeed - 6 Oct 2014
Mylan Launches Generic Combivir
Biopharmaceuticals Generics HIV/AIDS Product Launch

HSMN NewsFeed - 10 Sep 2014
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
Biopharmaceuticals Generics

HSMN NewsFeed - 5 Sep 2014
Mylan Launches Generic Boniva(R) Injection
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 11 Aug 2014
Mylan Launches Generic Xeloda(R) Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 14 Jul 2014
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 14 Jul 2014
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 29 May 2014
Mylan Launches Generic Malarone(R) Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 15 May 2014
Mylan Applauds Court's Ruling Dismissing Teva's Suit Against FDA on Copaxone(R)
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 4 Apr 2014
Statement by the Board of Directors of Meda
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Feb 2014
Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India
Biopharmaceuticals Product Launch

HSMN NewsFeed - 31 Jan 2014
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
Biopharmaceuticals Distribution

HSMN NewsFeed - 9 Jan 2014
Mylan Launches Generic Myfortic Delayed-Release Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 8 Jan 2014
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2014
Mylan Launches Generic Detrol(R) LA Capsules
Biopharmaceuticals Generics Urology Product Launch

HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Jul 2013
Pfizer To Create Separate, Internal, Global Innovative And Value Businesses
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2013
Mylan Announces STALEVO(R) Settlement Agreement
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 17 Jun 2013
InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Mylan Pharmaceuticals
Biopharmaceuticals Ophthalmology Generics Litigation

HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Dec 2012
Mylan Launches Generic Version of Qualaquin(R) Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Sep 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Aug 2012
Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 19 Jul 2012
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Biopharmaceuticals Generics Neurology Litigation

HSMN NewsFeed - 23 Feb 2012
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
Biopharmaceuticals Generics HIV/AIDS FDA

HSMN NewsFeed - 15 Feb 2012
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2011
Mylan Names John Thievon President of Dey Pharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2011
Mylan Receives Approval for Generic Version of Zinecard(R) for Injection
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Nov 2011
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Oct 2011
Mylan Announces New, Expanded Management Structure to be Effective Jan. 1, 2012
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
Biopharmaceuticals Litigation

HSMN NewsFeed - 20 Sep 2011
Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 9 Sep 2011
Mylan Receives Approval for Promethazine Hydrochloride Tablets, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals

HSMN NewsFeed - 22 Mar 2011
Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
Biopharmaceuticals Licensing Distribution Wound Care

HSMN NewsFeed - 28 Jan 2011
Mylan Receives Approval for First-to-File Generic Sular(R) Extended-Release Tablets
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 24 Jan 2011
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
Biopharmaceuticals Generics Gastroenterology FDA

HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 14 Dec 2010
KCI Selects David Lillback to Lead Global Human Resources
Devices Wound Care Personnel

HSMN NewsFeed - 15 Oct 2010
Mylan Receives Approvals for Generic Versions of Hyzaar(R) and Cozaar(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 22 Jul 2010
Mylan Announces Settlement Agreement for Namenda(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 14 Jul 2010
Mylan Receives Approval for Nabumetone Tablets
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jun 2010
Mylan Receives Approval for Generic Version of Arimidex(R) Tablets
Biopharmaceuticals Oncology Generics FDA

HSMN NewsFeed - 4 Jun 2010
Mylan Receives Approval for Generic Version of Neurontin(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 4 May 2010
Mylan Receives Approval for Generic Version of Zyban(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Apr 2010
Mylan Receives Approval for Generic Version of Flomax(R)
Biopharmaceuticals Generics Urology FDA

HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology

HSMN NewsFeed - 26 Apr 2010
Mylan Begins Marketing First Generic Version of Desoxyn(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Biopharmaceuticals Generics HIV/AIDS FDA

HSMN NewsFeed - 25 Feb 2010
Mylan Names John D. Sheehan Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2010
Noven Appoints Patrick Gallagher as Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2010
Mylan Receives Approval for Generic Version of GoLytely(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Jan 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 22 Dec 2009
Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 8 Dec 2009
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 15 Oct 2009
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Sep 2009
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Biopharmaceuticals Generics Neurology FDA

HSMN NewsFeed - 16 Sep 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Biopharmaceuticals Generics Dermatology

HSMN NewsFeed - 18 Aug 2009
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Jul 2009
Mylan Announces Enhancements to Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2009
Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2009
Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Jul 2009
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 17 Jun 2009
Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 May 2009
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Apr 2009
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
Biopharmaceuticals Oncology Generics Litigation

HSMN NewsFeed - 13 Apr 2009
Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2009
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Mar 2009
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Files Patent Infringement Lawsuits Against Teva Pharmaceuticals USA and Mylan Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Mar 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Biopharmaceuticals Generics FDA HIV/AIDS

HSMN NewsFeed - 9 Feb 2009
Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Biopharmaceuticals Generics

HSMN NewsFeed - 31 Jan 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 Jan 2009
Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
Biopharmacueticals Generics FDA

HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Biopharmaceuticals Generics Neurology FDA

HSMN NewsFeed - 23 Jan 2009
Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Jan 2009
Dey L.P. Settles State of Mississippi Pricing Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 Dec 2008
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
Biopharmaceuticals Generics FDA HIV/AIDS

HSMN NewsFeed - 2 Dec 2008
Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
Biopharmaceuticals Generics Oncology

HSMN NewsFeed - 26 Nov 2008
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Nov 2008
Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Nov 2008
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 4 Nov 2008
Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 22 Oct 2008
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Oct 2008
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Oct 2008
Bob Cunard Appointed President of Glades Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Sep 2008
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Aug 2008
Mylan Creates New Women's Health Care Franchise; Signs Agreement with Famy Care to Develop and Supply 22 Oral Contraceptive Products
Biopharmaceuticals

HSMN NewsFeed - 28 Jul 2008
Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Jul 2008
Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jul 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Jun 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Jun 2008
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Jun 2008
Mylan Wins Generic Prilosec(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Jun 2008
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 12 May 2008
Mystic Pharmaceuticals(TM) Expands Management, Engineering and Scientific Team with Key Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2008
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Apr 2008
Mylan Announces Final FDA Approval for Trandolapril Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 27 Feb 2008
Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2008
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2008
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2008
Mylan Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2008
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2008
Mylan Restores Availability of Generic Levothyroxine in Florida
Biopharmaceuticals Generics

HSMN NewsFeed - 1 Feb 2008
Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Jan 2008
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
Biopharmaceuticals Litigation

HSMN NewsFeed - 31 Dec 2007
Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Dec 2007
Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS Generics FDA

HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Nov 2007
Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2007
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2007
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2007
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 8 Oct 2007
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
Mylan Completes Acquisition of Generics Business of Merck KGaA
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of John Montgomery as President, Asia Pacific
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Mylan Announces Management of Specialty Business, Dey L.P.
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Heather Bresch as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Harry A. Korman as President, North America
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Sep 2007
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Sep 2007
Mylan Announces Tentative FDA Approval for Topiramate Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Sep 2007
Mylan Announces Final FDA Approval for Carvedilol Tablets
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Jun 2007
Teva Announces Approval of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 Jun 2007
Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Jun 2007
Thoratec Announces Appointment of Elisha Finney to Board of Directors; Names Neil Dimick Chairman and Don Hill Vice Chairman
Devices Cardiology Personnel

HSMN NewsFeed - 8 Jun 2007
Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 31 May 2007
Mylan Announces Final FDA Approval for Azithromycin Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 May 2007
Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 May 2007
Teva Comments About the Acquisition of Merck KGaA Generic Business
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 12 May 2007
Mylan Laboratories to Acquire Generics Business of Merck KGaA
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 3 May 2007
Mylan Announces Tentative FDA Approval for Letrozole Tablets, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 1 May 2007
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Biopharmaceuticals Generics Endocrinology FDA

HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Mar 2007
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
Biopharmaceuticals Generics

HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 2 Mar 2007
Actavis Launches Hydrochlorothiazide 12.5 mg Tablets in the U.S.
Biopharmaceuticals Generics

HSMN NewsFeed - 27 Feb 2007
Pfizer Wins Challenge to Norvasc Patent by Mylan
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Feb 2007
Mylan Provides an Update on Amlodipine Besylate Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 Feb 2007
Mylan Announces Final FDA Approval for Sertraline Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 Jan 2007
Mylan Laboratories Announces Strategic Global Reorganization to Maximize Growth Opportunities and Leverage Efficiencies Provided by New Global Platform
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Biopharmaceuticals Drug Delivery Generics FDA

HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 Jan 2007
The Practice of Authorized Generics During the 180-Day Exclusivity Period May Be Nearing its End With the Introduction of S. 438 - 'The Fair Prescription Drug Competition Act of 2007'
Biopharmaceuticals Generics

HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Jan 2007
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Dec 2006
Celsion Corporation Announces New President/CEO
Devices Urology Personnel

HSMN NewsFeed - 6 Dec 2006
Mylan Announces the Hiring of David F. Mulder to the Position of Senior Vice President, Corporate and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Nov 2006
Mylan Announces Final FDA Approval for Doxycycline Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 24 Oct 2006
U.S. District Court Grants Request for Preliminary Injunction to Ortho-McNeil Neurologics, Inc. for TOPAMAX(R)
Biopharmaceuticals Neurology Generics Litigation

HSMN NewsFeed - 24 Oct 2006
Onset Therapeutics Features Three Scientific Posters at ASWC on Recently Launched OPTASE(TM), a Novel Wound Care Gel
Biopharmaceuticals Wound Care

HSMN NewsFeed - 16 Oct 2006
U.S. District Court Upholds RISPERDAL(R) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Sep 2006
Mylan Announces Final FDA Approval for Topiramate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Sep 2006
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Jul 2006
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 24 May 2006
Mylan Announces Tentative Approval for Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 May 2006
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 129

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 129 additional stories matching:
Mylan
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.